You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ant-tuberculous agent

Showing 26 - 50 of 6,368
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Genitourinary Syndrome of Menopause, Sexual Function Disturbances Trial in Istanbul (injectable multifractional intercalated

Completed
  • Genitourinary Syndrome of Menopause
  • Sexual Function Disturbances
  • injectable multifractional intercalated hyaluronic acid [Armonia®, Regenyal, Italy]
  • İstanbul, Turkey
    Maltepe University Faculty of Medicine
Sep 28, 2022

Spectrum of Bacterial Infections in Rheumatology

Completed
  • Articular Disease
  • Groups/Cohortes
  • Pontoise, France
    Department of Rheumatology, Hospital René Dubos, Pontoise
Jan 25, 2022

Carious Lesion Trial in Islamabad (Adhesive resin restoration using Titania nanoparticle reinforced bonding agent, Adhesive

Enrolling by invitation
  • Carious Lesion
  • Adhesive resin restoration using Titania nanoparticle reinforced bonding agent
  • Adhesive resin restoration without Titania nanoparticle incorporated bonding agen
  • Islamabad, Pakistan
    School of Dentistry, Pakistan Institute of Medical Sciences
Feb 24, 2023

Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

Not yet recruiting
  • Breast Cancer
  • +7 more
  • (no location specified)
Sep 26, 2023

Hydroxychloroquine Trial in Assiut (Hydroxychloroquine, Folic Acid, Low-dose aspirin)

Active, not recruiting
  • Hydroxychloroquine
  • Assiut, Egypt
    Abdel-rahman Mahmoud Mohammed
Jul 21, 2021

Malignant Tumor Trial in Chendu (EBV immunological agent)

Recruiting
  • Malignant Tumor
  • EBV immunological agent
  • Chendu, Sichuan, China
    West China Hospital
Jan 31, 2023

Postpartum Pregnancy-Induced Hypertension, Postpartum Preeclampsia, Pregnancy-Induced Hypertension in Postpartum Trial in New

Not yet recruiting
  • Postpartum Pregnancy-Induced Hypertension
  • +3 more
  • New York, New York
    Columbia University Irving Medical Center
Jan 6, 2023

NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Sep 6, 2023

Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Pavia, Lombardia, Italy
    Istituti Clinici Scientifici Maugeri
May 5, 2023

Intubation Complication Trial in Karachi (Intravenous morphine)

Completed
  • Intubation Complication
  • Intravenous morphine
  • Karachi, Sind, Pakistan
    PNS Shifa Hospital
Oct 1, 2023

Tuberculosis, Tuberculous Meningitis, Drug-Induced Liver Injury Trial in Jakarta, Ho Chi Minh City (Dexamethasone, Placebo)

Active, not recruiting
  • Tuberculosis
  • +4 more
  • Jakarta, Indonesia
  • +5 more
Jun 29, 2022

Pulmonary Disease Due to Mycobacteria (Diagnosis) Trial in Worldwide (Amikacin, Tigecycline, Imipenem)

Recruiting
  • Pulmonary Disease Due to Mycobacteria (Diagnosis)
  • South Brisbane, Queensland, Australia
  • +36 more
Sep 12, 2022

Advanced Solid Tumors Trial in Worldwide (ASP1948, nivolumab, pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • New Haven, Connecticut
  • +41 more
Jan 10, 2023

Advanced Solid Tumors Trial in Worldwide (ASP1951, pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • Tucson, Arizona
  • +31 more
Jan 10, 2023

Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)

Not yet recruiting
  • Tuberculous Meningitis
  • High dose rifampicin (25mg/kg)
  • +8 more
  • Chennai, Tamil Nadu, India
    ICMR- National Institute for Research in Tuberculosis
Jun 15, 2023

Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • +2 more
  • (no location specified)
Aug 16, 2023

To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)

Not yet recruiting
  • To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)
  • (no location specified)
Aug 29, 2023

Ovarian Cancer Trial (Gleolan)

Not yet recruiting
  • Ovarian Cancer
  • (no location specified)
Mar 27, 2023

Superficial Digital Flexor Tendonitis Trial in Zürich (Genipin)

Completed
  • Superficial Digital Flexor Tendonitis
  • Zürich, ZH, Switzerland
    Equine surgery, Vetsuisse-Faculty, University of Zurich
Feb 22, 2023

Triple Negative Breast Cancer, Clear Cell Renal Cell Carcinoma, Ovarian Cancer Trial in Austin, San Antonio, Fairfax (BDC-3042,

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Austin, Texas
  • +2 more
Sep 19, 2023

Study of Mycobacterial Infections

Recruiting
  • Mycobacterium Infections
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Anesthesia Trial in Baghdad (melatonin)

Not yet recruiting
  • Anesthesia
  • Baghdad, Thi-Qar, Iraq
    Ministry of Health
Sep 2, 2023

Chronic Hepatitis B Trial in Seoul (Standard of care)

Active, not recruiting
  • Chronic Hepatitis B
  • Standard of care
  • Seoul, Korea, Republic of
  • +3 more
Mar 29, 2023

Cancer Trial (Ipatasertib)

Not yet recruiting
  • Cancer
  • (no location specified)
May 16, 2023

Desmoid Tumor Trial in Palo Alto (Nirogacestat, Cryoablation)

Not yet recruiting
  • Desmoid Tumor
  • Palo Alto, California
    Stanford University
Jul 7, 2023